The Stocks in Action || Do you know these buzzing stocks under the spotlight?

The programme touches upon price-sensitive announcements during early trading hours in the Australian market that would impact stock movement. Watch The Stocks in Action on Kalkine TV and stay updated.

• Medlab Clinical (ASX:MDC), an Australian biotech using delivery platforms to enhance medicine has shared that it has got human ethics approval for Australian sites for the NanaBis™ Cancer bone pain Phase III trial.

• Belberry Limited, a well-known Australian Human Research Ethics Committee (HREC), has granted approvals for Principal Investigators Prof Stephen Clarke at GenesisCare, Sydney and Prof Phil Good at the Mater Hospital, Brisbane.

• Well, NanaBis™ is Medlab’s most advanced non-opioid pain medication utilising Medlab’s patented, delivery platform, NanoCelle®.

• Shares of NRW were trading high, post the company updated it would sell its major mining equipment to Boggabri Coal Operations.

• Boggabri Coal is a part of Idemitsu Group and can exercise options to acquire a majority of mining equipment of Golding Contractors, a wholly-owned subsidiary of NWH, engaged in the Maintenance of the Boggabri Coal Mine.

• TheraJoint+, a highly potent turmeric supplement, was created after conducting a deep dive survey. The responses revealed significant consumer demand for a solution to the discomfort of joint pain and general whole-body inflammation.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK